April 2026 marks an inflection point for private healthcare in Singapore. New insurance regulations took effect on April 1 mandating new riders with greater co-pays and deductibles in exchange for lower premiums.
A day later, Foundation Healthcare Holdings, the Temasek-backed (through fully-owned Seatown Holdings) multi-specialist group released an estimate that “30 to 35 per cent of cases currently managed in local hospitals can already be moved out to day surgery centres”.
And then, last week, at Mount Alvernia Hospital’s 65th Anniversary celebrations, Health Minister Ong Ye Kung announced plans for a 300- to 400-bed not-for-profit hospital in the eastern part of Singapore. Noting it would be nearly two decades since land was last released for a private hospital, he said the move was intended to “encourage the establishment of lower-cost private hospitals” and the tender would fix the price of land and restrict bill sizes charged.
Taken together, these three milestones signal a deliberate attempt to push private healthcare away from a high-cost, volume-driven model towards one that is more disciplined, efficient and affordable.
Two structural realities underpin this shift.
First, demand for healthcare will increase inexorably with an ageing population. There is nothing that anyone can do to change this. But while demographics may be destiny, they alone do not dictate costs. How care is delivered and paid for will determine whether healthcare spending remains sustainable.
Second, private healthcare is very much alive and kicking despite acerbic comments about over-servicing and over-charging. In fact, Mr Ong’s pointed reference to the 1993 White Paper on Affordable Healthcare target of private hospitals providing 30 per cent of beds nationally suggests that policymakers still see a significant role for the sector if it evolves.
A well-functioning private healthcare sector is integral to Singapore’s economy. We have over 650,000 foreigners working and living here, not including work permit holders and domestic workers, and thousands of high-net-worth individuals regionally that admire Singapore-standard healthcare and are prepared to pay for this.
Choice is also fundamental in the Singapore model whether in healthcare, education or any other sector. Private hospitals allow patients to trade off cost, speed and amenities and also relieve pressure on public hospitals, providing added national healthcare capacity and aiding policymakers with further patient segmentation.
A third noteworthy point is that healthcare can contribute meaningfully to Singapore’s GDP and create many jobs. Healthcare jobs are good jobs – skilled, in general well-paying and less susceptible to automation and AI.
Finally, our investments in biomedical research need platforms locally and regionally for piloting and scaling, and done right, private healthcare groups can play this role. For example, IHH, one of the world’s largest healthcare groups, which operates in Singapore brands including Mount Elizabeth Hospital, Gleneagles and Parkway Shenton, is an investor in ASTAR-spin out companies, Us2.ai and Lucence and can help them grow globally.
